Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports ...

Moderna reports higher revenue but posts a loss

Moderna reported an increase in revenue during the first quarter, citing higher Covid-19 vaccine sales in international ...

Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earnings

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) reported first quarter 2026 revenue that came in well above Wall Street expectations, ...

Moderna Q1 preview: revenue rebound in focus as losses persist

Moderna (MRNA) reports Q1 earnings May 1 premarket—see consensus EPS (-$3.96), revenue ($236M), and estimate revisions to ...

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...
PharmExec

BMS vs. Moderna vs. Pfizer: The RNA Platform Race

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...

Moderna Sales Triple To $389 Million As Shares Rise 5.4%

Moderna's first-quarter sales beat expectations, fueled by government deals outside the US and its first UK shipment under a long-term agreement.
Blockonomi

Moderna (MRNA) Surges Nearly 8% as Q1 Revenue Crushes Wall Street Forecasts

Moderna (MRNA) shares surge 8% after Q1 revenue hits $389M, tripling year-over-year and beating estimates on strong ...